A Biochemical Analysis of Patients with COVID-19 Infection

Several studies have demonstrated that age, comorbidities, and abnormalities in different clinical biomarkers can be important to understand disease severity. Although clinical features of COVID-19 have been widely described, the assessment of alterations of the most common biochemical markers that...

Full description

Saved in:
Bibliographic Details
Main Authors: Adil R. Sarhan, Thaer A. Hussein, Mohammed H. Flaih, Khwam R. Hussein
Format: Article
Language:English
Published: Wiley 2021-01-01
Series:Biochemistry Research International
Online Access:http://dx.doi.org/10.1155/2021/1383830
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849695528766406656
author Adil R. Sarhan
Thaer A. Hussein
Mohammed H. Flaih
Khwam R. Hussein
author_facet Adil R. Sarhan
Thaer A. Hussein
Mohammed H. Flaih
Khwam R. Hussein
author_sort Adil R. Sarhan
collection DOAJ
description Several studies have demonstrated that age, comorbidities, and abnormalities in different clinical biomarkers can be important to understand disease severity. Although clinical features of COVID-19 have been widely described, the assessment of alterations of the most common biochemical markers that are reported in patients with COVID-19 still has not been well established. Here, we report clinical and blood biochemical indicators of 100 patients with COVID-19. Throat-swab upper respiratory samples were obtained from patients and real-time PCR was used to confirm SARS-CoV-2 infection. Gender, age, and clinical features such as diabetes mellitus, hypertension, and smoking habits were investigated. Biochemical parameters were categorized and analyzed according to these clinical characteristics. Triglycerides, GPT, and ALP are the biochemical markers that changed the most in the group of hypertension patients. Cholesterol and triglycerides were significantly different (P=0.01; P=0.04, respectively) between diabetic and nondiabetic patients with COVID-19. Potassium levels were significantly different (P=0.03) when comparing smokers with nonsmoker patients. Our results suggest several potential biochemical indexes that changed in patients with COVID-19 and whether certain comorbidity and clinical characteristics influence these markers.
format Article
id doaj-art-d03eda06c1ca4d8a98cb0a7da84cd7c0
institution DOAJ
issn 2090-2247
2090-2255
language English
publishDate 2021-01-01
publisher Wiley
record_format Article
series Biochemistry Research International
spelling doaj-art-d03eda06c1ca4d8a98cb0a7da84cd7c02025-08-20T03:19:45ZengWileyBiochemistry Research International2090-22472090-22552021-01-01202110.1155/2021/13838301383830A Biochemical Analysis of Patients with COVID-19 InfectionAdil R. Sarhan0Thaer A. Hussein1Mohammed H. Flaih2Khwam R. Hussein3Department of Medical Laboratory Techniques, Nasiriyah Technical Institute, Southern Technical University, Nasiriyah 64001, IraqDepartment of Medical Laboratory Techniques, Nasiriyah Technical Institute, Southern Technical University, Nasiriyah 64001, IraqDepartment of Medical Laboratory Techniques, Nasiriyah Technical Institute, Southern Technical University, Nasiriyah 64001, IraqDepartment of Medical Laboratory Techniques, Nasiriyah Technical Institute, Southern Technical University, Nasiriyah 64001, IraqSeveral studies have demonstrated that age, comorbidities, and abnormalities in different clinical biomarkers can be important to understand disease severity. Although clinical features of COVID-19 have been widely described, the assessment of alterations of the most common biochemical markers that are reported in patients with COVID-19 still has not been well established. Here, we report clinical and blood biochemical indicators of 100 patients with COVID-19. Throat-swab upper respiratory samples were obtained from patients and real-time PCR was used to confirm SARS-CoV-2 infection. Gender, age, and clinical features such as diabetes mellitus, hypertension, and smoking habits were investigated. Biochemical parameters were categorized and analyzed according to these clinical characteristics. Triglycerides, GPT, and ALP are the biochemical markers that changed the most in the group of hypertension patients. Cholesterol and triglycerides were significantly different (P=0.01; P=0.04, respectively) between diabetic and nondiabetic patients with COVID-19. Potassium levels were significantly different (P=0.03) when comparing smokers with nonsmoker patients. Our results suggest several potential biochemical indexes that changed in patients with COVID-19 and whether certain comorbidity and clinical characteristics influence these markers.http://dx.doi.org/10.1155/2021/1383830
spellingShingle Adil R. Sarhan
Thaer A. Hussein
Mohammed H. Flaih
Khwam R. Hussein
A Biochemical Analysis of Patients with COVID-19 Infection
Biochemistry Research International
title A Biochemical Analysis of Patients with COVID-19 Infection
title_full A Biochemical Analysis of Patients with COVID-19 Infection
title_fullStr A Biochemical Analysis of Patients with COVID-19 Infection
title_full_unstemmed A Biochemical Analysis of Patients with COVID-19 Infection
title_short A Biochemical Analysis of Patients with COVID-19 Infection
title_sort biochemical analysis of patients with covid 19 infection
url http://dx.doi.org/10.1155/2021/1383830
work_keys_str_mv AT adilrsarhan abiochemicalanalysisofpatientswithcovid19infection
AT thaerahussein abiochemicalanalysisofpatientswithcovid19infection
AT mohammedhflaih abiochemicalanalysisofpatientswithcovid19infection
AT khwamrhussein abiochemicalanalysisofpatientswithcovid19infection
AT adilrsarhan biochemicalanalysisofpatientswithcovid19infection
AT thaerahussein biochemicalanalysisofpatientswithcovid19infection
AT mohammedhflaih biochemicalanalysisofpatientswithcovid19infection
AT khwamrhussein biochemicalanalysisofpatientswithcovid19infection